Amgen's $28B Horizon buyout cleared for takeoff after FTC, states settle
Fierce Pharma
SEPTEMBER 1, 2023
After months of legal wrangling, Amgen is free to go forward with its $27.8 billion buyout of Horizon Therapeutics. Federal Trade Commission (FTC) said it reached a proposed consent order with Amgen to address “the potential competitive harm” that could result from the merger deal. Friday, the U.S.
304 
Let's personalize your content